Vir Biotechnology Financial Overview
Vir Biotechnology's market cap is currently $901.53M. The company's EPS TTM is $-1.17; its P/E ratio is -1.70; Vir Biotechnology is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
